Navigation Links
Mercury Therapeutics, Inc: Lead Series of Indirect AMPK Activators Licensed to Makoto Life Sciences
Date:3/12/2008

WOBURN, Massachusetts, March 12 /PRNewswire/ -- Mercury Therapeutics, Inc. (MTI), a company that discovers and develops orally active protein kinase targeted drugs, announces that it has signed an exclusive license agreement with Makoto Life Sciences, Inc., of Cambridge, Massachusetts.

Under this agreement, MTI has licensed to Makoto its lead series of high potency activators of AMP-activated protein kinase (AMPK), a well validated drug target for the treatment of Type-2 diabetes. As part of the license, MTI will transfer all assets related to its MT-39 series of indirect AMPK activators, including all materials, research notes, synthetic routes, and the structures of over 40 compounds. MTI will advise Makoto on the continuing development of the MT-39 series.

Unlike MTI's internal R&D program, which is focused on developing small molecules that activate AMPK by direct binding, the MT-39 series of compounds are indirect AMPK activators and appear to act with high potency through a cellular pathway which has not yet been identified. The successful clarification of this pathway may lead to the development of new targets and compounds for the treatment of metabolic disease.

MTI's series of compounds were originally identified in the course of a collaboration with Aventis, a large pharmaceutical company. That relationship ended in 2004 and all rights, including the MT-39 series of compounds, reverted entirely and exclusively to Mercury. MTI subsequently launched a medicinal chemistry program targeting the MT-39 core structure, and identified a number of congeners with low nanomolar activities and efficacy in animal models of glucose metabolism. As activators of AMPK, the MT-39 series of compounds could be expected to improve glycemic control in Type-2 diabetics, and lower other risk factors associated with cardiovascular disease.

While the specific terms of the license agreement have not been disclosed, Makoto will be responsible, among
'/>"/>

SOURCE Mercury Therapeutics Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Cell Therapeutics, Inc. (CTI) to Present at 7th Annual WBBA Invest Northwest Conference
2. Cell Therapeutics, Inc. (CTI) to Report Fourth Quarter and Year-End Financial Results on March 13
3. Cell Therapeutics, Inc. to Hold Conference Call to Update on Recent Transactions and Upcoming Milestones
4. M. Scott Harris, M.D., Joins Ocera Therapeutics, Inc., as Chief Medical Officer
5. Cell Therapeutics, Inc. (CTI) Announces Cancellation of Approximately $9.1 Million of Existing Notes due 2008
6. Mersana Therapeutics, Inc. Appoints Chief Scientific Officer, Timothy B. Lowinger, Ph.D.
7. Cell Therapeutics, Inc. (CTI) Projects Zevalin(R) Sales of $15 Million With Cash Flow Breakeven for Commercial Operations in 2008
8. Cell Therapeutics, Inc. (CTI) to Present at 10th Annual BIO CEO & Investor Conference
9. Nile Therapeutics, Inc. to Present at Upcoming BIO CEO & Investor Conference
10. Velcura Therapeutics, Inc. Teams with International Discovery Sourcing Consultants to Develop New Therapeutic Molecules for Cancer and Bone Disease
11. Sonexa Therapeutics, Inc., Raises $30 Million in Series A Financing to Focus on Alzheimers Treatments
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/5/2008)...test pilots push planes to explore their limits, r...and Technology (NIST) are probing the newest micro...curacy at the nanoscale. Better nanoscale measurem...ing production in the semiconductor and nanomanufa...logy uses helium ions to generate the signal used ...
(Date:9/5/2008)...e Food & Drug Administration (FDA) issued in July ...port acknowledged that nanoscale materials potenti... by the agency and that those materials present ch...elevant to product safety and effectiveness may ch...icipating the potential for rapid commercializatio...
(Date:9/5/2008)...us, gold is only valuable if we possess it in larg...le isn,t the case for those interested in exploiti...ariety of chemical reactions, including the oxidat...s carbon dioxide at room temperatures. That proces...e effectiveness of catalytic converters that clean...
(Date:9/5/2008)...ept. 5 /- Gen-Probe Incorpo...mpany will present at the Morgan,Stanley Global He...r 9,2008 at approximately 2:45 p.m. Eastern Time....and may be accessed through a link on the investor...n-probe.com . The webcast,will be available for 30...
Breaking Biology Technology:NIST studies how new helium ion microscope measures up 2Nanotechnology and the FDA: size matters 2NIST and partners identify tiny gold clusters as top-notch catalysts 2Gen-Probe to Webcast Presentation at the Morgan Stanley Global Healthcare Unplugged Conference 2
...local and national radio advertising for small bus... and its Audio Ads network includes hundreds of ra...t mean for marketers who need to create a radio ad.... , ,"Over the last year, we,ve been partnering wi...cross the U.S. so that our advertisers have many o...
...Mexico-based biotechnology company, has selected t...o manufacture its DNA-based, pre-flu vaccine. , ... Waisman Center , the biomanufacturing facility is... pharmaceutical products for Phase I and II human ...ials underway before the end of next year,s flu se...
...w strategic plan featuring enhancements to 25 rout...s announced the launch of nonstop Midwest Connect ..., the airport that serves Research Triangle Park ... fending off a hostile takeover bid by AirTran Hol...equested destination of business travelers because...
...ered the spawning ground for the next wave of high...growth in the national angel market, a diversified...ional investors. , ,In its 2006 Angel Market Anal...niversity of New Hampshire reports that angel inv...al investments of $25.6 billion. , ,A report on 2...
Other Biology Technology:See how they run: Radio ads and Google 2See how they run: Radio ads and Google 3See how they run: Radio ads and Google 4National angel investment grew 11 percent in `06 2National angel investment grew 11 percent in `06 3
(Date:9/5/2008)...work as recently illustrated by the flightless and...a. This cricket relative is found in New Zealand a...ales weighing in at 20 g, averaging twice the size...aland, published in the September issue of The Am...he University of Toronto at Mississauga discovered...
(Date:9/5/2008)... challenge of surviving in a changing climate. Res...Claude Bernard Lyon have shown how a sheep populat...and responds to two consequences of climate change...ty of winter storms. Dr. Thomas Ezard, lead author...food is plentiful, lambs contribute almost twice a...
(Date:9/5/2008)...nies of a critically endangered vulture, whose num...ns to a few thousand, are too small to protect the... analysis shows. , Adding wild birds to the capt...ucial, but political and logistical barriers are h.... , The study was published online August 15 in ...
(Date:9/5/2008)...e Gustav is shown via a sequence of satellite imag... Spectrometer (MERIS) instrument on 25 August, 28 ... to left). , Gustav formed on 25 August 2008 som...above far right image), when a tropical wave devel...visible), causing the U.S. National Hurricane Cent...
Breaking Biology News(10 mins):Lightweight and long-legged males go the distance for sex 2Recovery efforts not enough for critically endangered Asian vulture 2Recovery efforts not enough for critically endangered Asian vulture 3Hurricane Gustav 2Nuvo Research and Paladin announce amendments to Pennsaid and Pennsaid Plus agreements 23428 1Nuvo Research and Paladin announce amendments to Pennsaid and Pennsaid Plus agreements 23428 2Nuvo Research and Paladin announce amendments to Pennsaid and Pennsaid Plus agreements 23428 3Yale Keck Microarray Center Becomes a GeneGo Center of Excellence 6405 1Yale Keck Microarray Center Becomes a GeneGo Center of Excellence 6405 2Pharmasset Announces Initiation of Combination Study of Clevudine and Viread 28R 29 for HBV by French National Agency for Research on AIDS and Viral H 2591 1Pharmasset Announces Initiation of Combination Study of Clevudine and Viread 28R 29 for HBV by French National Agency for Research on AIDS and Viral H 2591 2Pharmasset Announces Initiation of Combination Study of Clevudine and Viread 28R 29 for HBV by French National Agency for Research on AIDS and Viral H 2591 3Pharmasset Announces Initiation of Combination Study of Clevudine and Viread 28R 29 for HBV by French National Agency for Research on AIDS and Viral H 2591 4Embryo biopsy does not affect early growth and risk of congenital malformations in PGD PGS babies 3931 1Embryo biopsy does not affect early growth and risk of congenital malformations in PGD PGS babies 3931 2Embryo biopsy does not affect early growth and risk of congenital malformations in PGD PGS babies 3931 3
...er blood vessels within the tissue of previously e...ignificant improvement in heart function. The stu... , With heart disorders affecting individuals glo...es, there has been a need to develop new treatment...ield of tissue engineering is to produce blood ves...
...ts will be the first in the area to insert a new t...hink of it as a contact lens inside your eye," sai...lantable collamer lens, or ICL, today for the firs... The ICL can replace or reduce the need for glasse...ficial lens in front of the eye,s natural lens, ra...
...ed breakdown of myelin, the fatty insulation coati...y with the presence of a key genetic risk factor f...in the January edition of the peer-reviewed journa...ing body of evidence that myelin breakdown is a ke...ter in life. , In addition, the study demonstrate...
...report describing the occurrence of pesticides in ...ort concludes that pesticides are typically presen... agricultural areas of the Nation, but are less co...hat pesticides are seldom at concentrations likely...cularly those draining urban and agricultural area...
Other Biology News:New 'implanted contacts' designed to fix nearsightedness 2Imaging study links key genetic risk for Alzheimer's disease to myelin breakdown 2Pesticides in the nation's streams and ground water 2Pesticides in the nation's streams and ground water 3Pesticides in the nation's streams and ground water 4
BD FACSAria Cell Sorting System from BD Biosciences - Immunocytometry Systems
Kit Components: Anti-PARP LumiGLO Chemiluminescent Substrate Immunoblot Blocking Reagent Pyronin Y Reagent Goat Anti-Rabbit IgG, HRP conjugate Double-It Reagent Film Exposure Folders Autor
...nt/server version of Freezerworks Unlimited includ...kflow in high-volume labs and facilitates the shar...d to share sample information. Network Clien...PC 601); 13 in monitor with 256 colors; OS 8.6 & O...
Polypropylene test tube racks, used in Thermo Forma's line of Test Tube Rack holders
Biology Products: